Pharma Reviews: Let's make in India, says Pharma devices sector

NEW DELHI: Bringing 'Make in India' to the pharma sector, the government will come out with a Bill to regulate medical devices such as CT scanners, ...
Read more: Let's make in India, says Pharma devices sector

Pharma Reviews: With Brexit Indian pharma industry could capitalize on falling GBP to invest & acquire cos in UK ...

In the Brexit phase Indian industry including pharmaceuticals will need to capitalize on the falling value of British currency to invest and acquire ...
Read more: With Brexit Indian pharma industry could capitalize on falling GBP to invest & acquire cos in UK ...

Pharma Reviews: Greenfield FDI norm hardly helpful in asset building in pharma industry: CIPI

... to allow 100 per cent FDI under automatic route in greenfield pharma projects, the Confederation of Indian Pharmaceutical Industry (CIPI) stated that ...
Read more: Greenfield FDI norm hardly helpful in asset building in pharma industry: CIPI

Pharma Reviews: New IPR policy to benefit MSMEs pharma sector with innovation: Dr Gopakumar Nair

Medium and small scale pharma units in India need to update themselves to survive in changing regulatory and intellectual property environment.
Read more: New IPR policy to benefit MSMEs pharma sector with innovation: Dr Gopakumar Nair

Pharma Reviews: Cipla, Aurobindo Pharma to acquire drugs from Teva

Cipla Ltd and Aurobindo Pharma Ltd have agreed to acquire some generic drugs from Teva Pharmaceutical Industries Ltd in the US, as the Indian ...
Read more: Cipla, Aurobindo Pharma to acquire drugs from Teva

Pharma Reviews: Drug makers need to jointly address quality issues, says Dr Reddy's chairman

Reddy told a shareholders' meeting that the Indian Pharmaceutical Alliance (IPA)—the industry lobby group that represents large domestic Indian ...
Read more: Drug makers need to jointly address quality issues, says Dr Reddy's chairman

Pharma Reviews: India, Japan discuss trade, investment to fix irritants

India also sought recognition of the Indian organic standards by Japan. ... opportunity for the Indian pharma industry, which is strong in generics.
Read more: India, Japan discuss trade, investment to fix irritants

Pharma Reviews: India seeks greater market access for pharma, marine products from Japan

NEW DELHI: India has sought greater market access for its pharmaceuticals and marine products in Japan as part of expanding trade with Tokyo.
Read more: India seeks greater market access for pharma, marine products from Japan

Pharma Reviews: 3rd meeting of the Joint Committee at the Secretary Level under the India-Japan CEPA

The Indian side was led by Rita Teaotia, Commerce Secretary and the ... opportunity for the Indian Pharma Industry, which is strong in generics.
Read more: 3rd meeting of the Joint Committee at the Secretary Level under the India-Japan CEPA

Pharma Reviews: Biggest Indian acquisition by a Chinese company: Fosun to buy Gland Pharma for $1.26 billion

Hong Kong: The pharmaceutical arm of Chinese conglomerate Fosun plans to buy a majority stake in India`s Gland Pharma Ltd. for as much as $1.26 ...
Read more: Biggest Indian acquisition by a Chinese company: Fosun to buy Gland Pharma for $1.26 billion

Pharma Reviews: BREAKINGVIEWS-India pharma deal suggests Fosun is an M&A junkie

Shanghai Fosun Pharmaceutical on July 28 agreed to buy up to 86 percent of India's Gland Pharma for up to $1.3 billion. Hyderabad-based Gland ...
Read more: BREAKINGVIEWS-India pharma deal suggests Fosun is an M&A junkie

Pharma Reviews: Sun Pharmaceutical Industries Ltd in $50 million deal with Spanish firm

Sun Pharmaceutical Industries Ltd in $50 million deal with Spanish firm. Indian drug major Sun Pharmaceutical Industries Ltd said it entered into $50 ...
Read more: Sun Pharmaceutical Industries Ltd in $50 million deal with Spanish firm

Pharma Reviews: Fosun buys Gland Pharma for $1.3bn

Fosun is a Chinese conglomerate with interests in businesses such as wealth ... in the sector and point to the takeover of the Indian active pharmaceuticals ... Along with Shanghai Fosun Pharmaceutical, others in the fray to acquire a ...
Read more: Fosun buys Gland Pharma for $1.3bn

Pharma Reviews: China's Fosun to acquire majority stake in KKR-backed Gland Pharma for $1.26 bn

Ltd will acquire a majority stake in Hyderabad-based Gland Pharma Ltd for up to $1.26 billion (Rs 8,440 crore), the Indian company's private equity ...
Read more: China's Fosun to acquire majority stake in KKR-backed Gland Pharma for $1.26 bn

US FDA News: AVEA Ventilator by CareFusion: Class I Recall - Electrical Issue May Cause Unexpected Shutdown

Ventilator shutdown may cause serious adverse health consequences, including death.
Read more: AVEA Ventilator by CareFusion: Class I Recall - Electrical Issue May Cause Unexpected Shutdown

US FDA News: Statement from Peter Marks, M.D., Ph.D., Director, FDA’s Center for Biologics Evaluation and Research

The FDA is tasked with taking important steps to respond to the emerging Zika virus outbreak. One of the agency’s key public health responsibilities is to help ensure the safety of the nation’s blood supply.
Read more: Statement from Peter Marks, M.D., Ph.D., Director, FDA’s Center for Biologics Evaluation and Research

Pharma Reviews: Fosun agrees to buy KKR-backed Indian drugmaker Gland Pharma for up to $1.3 bn

HONG KONG/MUMBAI: Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy an 86 percent stake in Gland Pharma - backed by KKR ...
Read more: Fosun agrees to buy KKR-backed Indian drugmaker Gland Pharma for up to $1.3 bn

Pharma Reviews: Gland Pharma's deal with Fosun will open up new markets: Ravi Penmetsa, MD, Gland Pharma

China has been traditionally a competitor for Indian drug companies. Do you think this deal will impact business and perceptions for stakeholders?
Read more: Gland Pharma's deal with Fosun will open up new markets: Ravi Penmetsa, MD, Gland Pharma

Pharma Reviews: Fosun agrees to buy KKR-backed Indian drugmaker for up to $1.3 billion

Moody's Indian associate ICRA expects patents to expire on about $16 billion ... Gland Pharma's founders and U.S. private equity firm KKR jointly hold ...
Read more: Fosun agrees to buy KKR-backed Indian drugmaker for up to $1.3 billion

US FDA News: FDA approves Adlyxin to treat type 2 diabetes

The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.
Read more: FDA approves Adlyxin to treat type 2 diabetes

Pharma Reviews: Sun Pharma in $50 million deal with Spanish firm

CHENNAI: Indian drug major Sun Pharmaceutical Industries Ltd said it entered into $50 million licensing agreement with Spanish firm Almirall for the ...
Read more: Sun Pharma in $50 million deal with Spanish firm

Pharma Reviews: Pharma cos, Asian Paints, Bharti Airtel, Max India in focus

Some of the stocks that should be on your radar are: Lupin, Torrent Pharmaceuticals, RPG Life Sciences, Sun Pharmaceutical Industries, Asian Paints, ...
Read more: Pharma cos, Asian Paints, Bharti Airtel, Max India in focus

Pharma Reviews: Pharma cos engaged in R&D need to understand changes happening in the sector: Dr Shailesh ...

As far as Indian pharma sector is concerned, the major pharma companies in the country are concentrated on targeted therapies. Understanding of ...
Read more: Pharma cos engaged in R&D need to understand changes happening in the sector: Dr Shailesh ...

Pharma Reviews: China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billion

MUMBAI: In the first instance of a large foreign investment from China in an Indian manufacturing asset, Shanghai Fosun Pharmaceutical (Group) Co ...
Read more: China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billion

Pharma Reviews: Chinese drug maker Fosun to buy Gland Pharma for $1.5 billion

Ltd, the Hong Kong-listed company controlled by billionaire Guo Guangchang, will acquire 96% stake in India's Gland Pharma Ltd for $1.3-1.5 billion ...
Read more: Chinese drug maker Fosun to buy Gland Pharma for $1.5 billion

Pharma Reviews: Government working on regulating online sale of medicines: Commerce minister

Maintaining that the Indian pharma industry had made a mark in the world for its quality medicines, she said it was imperative upon them to ensure that ...
Read more: Government working on regulating online sale of medicines: Commerce minister

Pharma Reviews: Govt working on regulating web pharmacy: Sitharaman

Sitharaman said the Health Ministry and the drug regulator were ... Maintaining that the Indian pharma industry had made a mark in the ...
Read more: Govt working on regulating web pharmacy: Sitharaman

Pharma Reviews: Govt working on regulating web pharmacy: Sitharaman

Maintaining that the Indian pharma industry had made a mark in the world for its quality medicines, she said it was imperative upon them ...
Read more: Govt working on regulating web pharmacy: Sitharaman

Pharma Reviews: China's Fosun set to acquire KKR-backed Gland Pharma

Ltd is poised to acquire KKR-backed Indian drugmaker Gland Pharma Ltd for ... On Thursday, The Economic Times reported that the Chinese firm is ...
Read more: China's Fosun set to acquire KKR-backed Gland Pharma

Pharma Reviews: China's Fosun to acquire Gland Pharma for $1.4 bn: Reports

Chinese billionaire Guo Guangchang-led Shanghai Fosun Pharmaceutical Co Ltd is likely to acquire a significant stake in India's Gland Pharma Ltd ...
Read more: China's Fosun to acquire Gland Pharma for $1.4 bn: Reports

Pharma Reviews: POOR SHOW BY PHARMA COS

The Pharmabiz study of the performances of India's top 100 listed pharmaceutical companies during 2015-16 brings out a complex profile of this key ...
Read more: POOR SHOW BY PHARMA COS

Pharma Reviews: Is it time to look at pharma shares again?

Some of this is evident from the increased US FDA abbreviated new drug application (ANDA) approvals that have been granted to Indian companies.
Read more: Is it time to look at pharma shares again?

US FDA News: FDA updates warnings for fluoroquinolone antibiotics

The U.S. Food and Drug Administration today approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients with less serious bacterial infections.
Read more: FDA updates warnings for fluoroquinolone antibiotics

US FDA News: Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects

Use associated with disabling and potentially permanent side effects of the tendons, muscles, joints, nerves, and central nervous system that can occur together in the same patient.
Read more: Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects

Pharma Reviews: India rejects 955 pharma patent applications in last 3 years

India rejects 955 pharma patent applications in last 3 years. India has rejected as many as 955 patent applications in the pharmaceutical sector in the ...
Read more: India rejects 955 pharma patent applications in last 3 years

Pharma Reviews: Glenmark raises $200 mn in bonds and other top pharma news

This is the first dollar bond sale by an Indian pharmaceutical company. Glenmark raised the funds through a five-year bond issue with a coupon rate of ...
Read more: Glenmark raises $200 mn in bonds and other top pharma news

Pharma Reviews: India rejects 955 pharma patent applications in last 3 years

India has rejected as many as 955 patent applications in the pharmaceutical sector in the last three years. Nirmala Sitharaman said this in a written ...
Read more: India rejects 955 pharma patent applications in last 3 years

Pharma Reviews: e-Pharmacy to Provide Growth Opportunities for Pharma Companies and Last Mile Access of ...

The Federation of Indian Chambers of Commerce and Industry (FICCI) — an apex business organization — in association with Frost & Sullivan, ...
Read more: e-Pharmacy to Provide Growth Opportunities for Pharma Companies and Last Mile Access of ...

Pharma Reviews: HR firms find women prefer to work with younger bosses in pharma industry

Some of the major human resource service companies are of the opinion that Indian pharma industry having a hierarchical and conventional ...
Read more: HR firms find women prefer to work with younger bosses in pharma industry

Pharma Reviews: IPA Bihar wants state govt to establish centralized drug purchasing system in state

The Bihar branch of the Indian Pharmaceutical Association (IPA) wants the state government to establish a centralized drug purchasing system for the ...
Read more: IPA Bihar wants state govt to establish centralized drug purchasing system in state

US FDA News: HCG and Sermorelin by Talon Compounding Pharmacy: Recall - Lack of Sterility Assurance

Administration of a drug product intended to be sterile that is compromised can result in health hazards including risk of serious infection or other complications.
Read more: HCG and Sermorelin by Talon Compounding Pharmacy: Recall - Lack of Sterility Assurance

US FDA News: Angiodynamics Soft Vu Omni Flush Angiographic Catheter by Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions): Class I Recall - Tip Separation

Risk of surgical intervention to retrieve a separated segment, or other serious adverse health consequences such as internal organ injury, stroke, kidney failure, intestinal failure, and death.
Read more: Angiodynamics Soft Vu Omni Flush Angiographic Catheter by Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions): Class I Recall - Tip Separation

Pharma Reviews: New office of Tamil Nadu Pharmaceutical Sciences Welfare Trust to be operational next month

After inauguration, Dr Subburaju said the Indian pharma sector now provides 2.5 lakh million jobs to people belong to industry, research, trade and ...
Read more: New office of Tamil Nadu Pharmaceutical Sciences Welfare Trust to be operational next month

Pharma Reviews: Franklin Templeton, ICICI's bet on Indian pharma redemption pays in rally

Mumbai: India's pharmaceutical industry is helping lead an equity bull run as ... Franklin Templeton Investment's biggest India stock fund added to its ...
Read more: Franklin Templeton, ICICI's bet on Indian pharma redemption pays in rally

Pharma Reviews: Nifty Pharma index hits 2016 highs

Sun Pharmaceutical Industries, Aurobindo Pharma and Glenmark ... Earlier, this month, three Indian pharma companies - Lupin, Cadila Healthcare ...
Read more: Nifty Pharma index hits 2016 highs

Pharma Reviews: Drug approvals in India near record despite FDA inspection blitz

“Everything sounds negative around Indian pharma, but practically it's just a few companies,” said Surya Patra, an analyst at PhillipCapital India Pvt. in ...
Read more: Drug approvals in India near record despite FDA inspection blitz

Pharma Reviews: ICICI Prudential Life Becomes First Insurance Company to File For IPO

Indian pharmaceutical companies are eyeing the opportunity created by ... The company will also have 180-day shared exclusivity for the drug.
Read more: ICICI Prudential Life Becomes First Insurance Company to File For IPO

Pharma Reviews: Pharma firm at centre of probe owes Rs 1500 cr to investors

Pharma firm at centre of probe owes Rs 1,500 cr to investors ... to depositors and investors, according to documents reviewed by The Indian Express.
Read more: Pharma firm at centre of probe owes Rs 1500 cr to investors

Pharma Reviews: Three Indian drug firms get FDA nod

Aurobindo Pharma, Sun Pharma and Glenmark Pharmaceuticals have received USFDA approval for selling Rosuvastatin Calcium tablet, the generic ...
Read more: Three Indian drug firms get FDA nod

Pharma Reviews: India to Inject $3.4 Billion to Boost Capital at State Banks

State Bank, the nation's largest, will get 75.8 billion rupees, while Indian ... Indian pharmaceutical companies are eyeing the opportunity created by ...
Read more: India to Inject $3.4 Billion to Boost Capital at State Banks

Pharma Reviews: 3 Indian firms get USFDA nod for high-value generic drug

In what could boost their fortunes significantly, three Indian companies - Sun Pharma, Aurobindo Pharma and Glenmark Pharma - have received ...
Read more: 3 Indian firms get USFDA nod for high-value generic drug

Pharma Reviews: SBI, Brookfield Asset Management to Join Forces for Stressed Asset Fund

State Bank of India has signed an agreement with U.S.-based asset ... Indian pharmaceutical companies are eyeing the opportunity created by ...
Read more: SBI, Brookfield Asset Management to Join Forces for Stressed Asset Fund

Pharma Reviews: Trade With India Can Grow Exponentially, Former Pakistan PM Tells Bloomberg

Trade with India, he said, is inching up and has the potential to grow ... Indian pharmaceutical companies are eyeing the opportunity created by ...
Read more: Trade With India Can Grow Exponentially, Former Pakistan PM Tells Bloomberg

Pharma Reviews: IMF Trims India's FY17 Growth Forecast Citing Sluggish Investment Recovery

“In India, economic activity remains buoyant, but the growth forecast for ... Indian pharmaceutical companies are eyeing the opportunity created by ...
Read more: IMF Trims India's FY17 Growth Forecast Citing Sluggish Investment Recovery

Pharma Reviews: Indian Firms Get Approval for Generics of AstraZeneca Drug

India's Aurobindo Pharma Ltd., Glenmark Pharmaceuticals Ltd. and Sun Pharmaceutical Industries Ltd. received approval from the U.S. Food and ...
Read more: Indian Firms Get Approval for Generics of AstraZeneca Drug

Pharma Reviews: India's Government-Owned Banks Cheapest Amongst Asian Peers

Six Indian banks figure in the list of the bottom ten and all six are ... Indian pharmaceutical companies are eyeing the opportunity created by ...
Read more: India's Government-Owned Banks Cheapest Amongst Asian Peers

Pharma Reviews: AstraZeneca's Crestor Loss Opens Doors for Indian Pharma Firms

Indian pharmaceutical companies are eyeing the opportunity created by AstraZeneca Plc's failure to keep generic versions of its best-selling cholestrol ...
Read more: AstraZeneca's Crestor Loss Opens Doors for Indian Pharma Firms

Pharma Reviews: The Domestic and Global Risks of Foreign Direct Investment in India's Generics Industry

India needs a domestic pharmaceutical industry that is unfettered by foreign dominion and control, particularly by a rapacious multinational industry ...
Read more: The Domestic and Global Risks of Foreign Direct Investment in India's Generics Industry

Pharma Reviews: Brexit leaves tech in a jam, but pharma's not too bad

"Brexit led currency volatility should have limited impact on Indian pharma companies," said Anmol Ganjoo, Pharma analyst at JM Financial.
Read more: Brexit leaves tech in a jam, but pharma's not too bad

US FDA News: WEN by Chaz Dean Cleansing Conditioners: FDA Statement - Investigation of Adverse Event Reports

Reports of hair loss, hair breakage, balding, itching, and rash.
Read more: WEN by Chaz Dean Cleansing Conditioners: FDA Statement - Investigation of Adverse Event Reports

US FDA News: Federal court orders Minnesota sprout and noodle company to cease operations due to unsanitary conditions

On July 15, 2016, the U.S. District Court for the District of Minnesota entered a consent decree of permanent injunction between the United States and Kwong Tung Foods, Inc., doing business as Canton Foods; its president and owner, Vieta “Victor” C. Wang; and its vice-president, Juney H. Wang, for significant and ongoing violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) and its implementing regulations. The business, located in Minneapolis, Minnesota, sells rice and wheat noodles, and mung bean and soy bean sprouts.
Read more: Federal court orders Minnesota sprout and noodle company to cease operations due to unsanitary conditions

Pharma Reviews: Lack of GxP compliance put pharma companies under US FDA scanner: Ram Yeleswarapu

Data integrity challenges faced by a number of pharma industries in developing and third world countries including India are mainly due to ...
Read more: Lack of GxP compliance put pharma companies under US FDA scanner: Ram Yeleswarapu

Pharma Reviews: Indian pharma majors fail drug test

NEW DELHI: Medicines made by Indian pharmaceutical companies including Cipla, Pfizer, Dr Reddy's, Lupin and Sun Pharmaceuticals among others ...
Read more: Indian pharma majors fail drug test

Pharma Reviews: Meet India's next generation of women leaders in pharma

The Indian pharmaceutical and healthcare industry has long been dominated by men, a trait it shares with many of its counterparts abroad. But now a ...
Read more: Meet India's next generation of women leaders in pharma

Pharma Reviews: Net worth of 30 top Indian pharma cos move up by 20% in 2015-16

The top 30 Indian pharmaceutical companies, with net sales of above Rs. 1,000 crore, have built up strong reserves and surplus position during ...
Read more: Net worth of 30 top Indian pharma cos move up by 20% in 2015-16

US FDA News: Oral Liquid Docusate Sodium by PharmaTech : Recall - Contaminated with B. cepacia

The agency confirmed the product has been contaminated with Burkholderia cepacia, a bacteria linked to an outbreak in five states.
Read more: Oral Liquid Docusate Sodium by PharmaTech : Recall - Contaminated with B. cepacia

Pharma Reviews: Pharmaceutical Newsletter - July 11 to 16, 2016

The week ended July 16 saw major turnarounds in Indian pharma sector with Sun Pharma hogging the limelight by announcing role reversal for North ...
Read more: Pharmaceutical Newsletter - July 11 to 16, 2016

US FDA News: FDA approves first intraocular lens with extended range of vision for cataract patients

The U.S. Food and Drug Administration today approved the first intraocular lens (IOL) that provides cataract patients with an extended depth-of-focus, which helps improve their sharpness of vision (visual acuity) at near, intermediate and far distances.
Read more: FDA approves first intraocular lens with extended range of vision for cataract patients

Pharma Reviews: Expect mixed quarter for Indian pharma companies: Jefferies

We expect a mixed quarter for the Indian pharma sector. While US business should see strong growth led by exclusivity, base business performance ...
Read more: Expect mixed quarter for Indian pharma companies: Jefferies

Pharma Reviews: Pharma Companies May Report Strong Revenue Growth For Q1: Jefferies

Aurobindo Pharma continues to remain the outlier, receiving 40 per cent of the total Indian approvals (16). Sun and Lupin both got six approvals each ...
Read more: Pharma Companies May Report Strong Revenue Growth For Q1: Jefferies

Pharma Reviews: India's pharma market's missing the pep

After the US, India is the main contributor to sales for most Indian generic drug companies. Unfortunately, even the US market has not been in top form ...
Read more: India's pharma market's missing the pep

Pharma Reviews: Which sectors are on fund managers' radar?

USFDA has put pressure on Indian pharma companies to put their house in order. They will take little time to make adjustment but will surely come out ...
Read more: Which sectors are on fund managers' radar?

Pharma Reviews: Over 150 Indian Companies to Showcase at UBM India's PharmaLytica 2016

UBM India, organisers of CPhI and P-MEC India, the leading global pharma trade show and conference, today announced the 3rd edition of ...
Read more: Over 150 Indian Companies to Showcase at UBM India's PharmaLytica 2016

Pharma Reviews: Suven Life gets patent and other top pharma news

Kalyanasundaram Subramanian, or Kal Sundaram, an old hand at Sun Pharmaceutical Industries, is coming back home. He will be leading the India ...
Read more: Suven Life gets patent and other top pharma news

Pharma Reviews: "India has a competent enough system to check quality standards"

The $25-billion Indian pharma industry is going through intense regulatory scrutiny. Foreign drug regulators such as the US Food and Drug ...
Read more: "India has a competent enough system to check quality standards"

Pharma Reviews: Creador Capital close to investing Rs 118 crore for minority stake in Corona Remedies

It is already in talks with two smaller pharma companies for acquisition. Private equity firms have been bullish on the Indian pharma as it remains one ...
Read more: Creador Capital close to investing Rs 118 crore for minority stake in Corona Remedies

US FDA News: INRatio and INRatio2 PT/INR Monitor System by Alere: Recall - Potentially Inaccurate INR Results

Alere is working with the FDA to determine the most appropriate timing for product discontinuation and will provide guidance on transitioning patients to an alternate solution.
Read more: INRatio and INRatio2 PT/INR Monitor System by Alere: Recall - Potentially Inaccurate INR Results

US FDA News: FDA approves new medication for dry eye disease

The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease, on Monday, July 11, 2016. Xiidra is the first medication in a new class of drugs, called lymphocyte function-associated antigen 1 (LFA-1) agonist, approved by the FDA for dry eye disease.
Read more: FDA approves new medication for dry eye disease

Pharma Reviews: Indian companies gearing up to solve the biosimilars puzzle

This provided an opportunity to Indian pharma companies, active in ... Many of the Indian companies – such as Biocon, Dr Reddy's, Zydus Cadila, ...
Read more: Indian companies gearing up to solve the biosimilars puzzle

Pharma Reviews: Indian pharma market crosses Rs 1 lakh cr MAT; growth slows

The Indian pharma market (IPM) growth might have slowed down in the past few months for a combination of factors including price control and ban ...
Read more: Indian pharma market crosses Rs 1 lakh cr MAT; growth slows

Pharma Reviews: FDI in Brownfield pharma projects may help to increase exports, supportive to SSIs: TN IDMA

Fully agreeing with the point that 100 per cent FDI in Greenfield pharmaceutical projects in India is dangerous to domestic pharma sector, the ...
Read more: FDI in Brownfield pharma projects may help to increase exports, supportive to SSIs: TN IDMA

US FDA News: FDA approves first MRI-guided focused ultrasound device to treat essential tremor

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors.
Read more: FDA approves first MRI-guided focused ultrasound device to treat essential tremor

Pharma Reviews: Indian Pharma market clocks lowest growth of 6.4% in June 2016

The Indian Pharmaceutical Market (IPM) has clocked a growth of 6.4 per cent only during June 2016 which touched to Rs.8,460 crore as against ...
Read more: Indian Pharma market clocks lowest growth of 6.4% in June 2016

Pharma Reviews: Modi Says India is the Most Open Economy. Reality is Far More Complex.

The pharmaceutical industry has turned out to be a spectacular “Make in India” success story even before the NDA had launched the project under its ...
Read more: Modi Says India is the Most Open Economy. Reality is Far More Complex.

Pharma Reviews: Sun Pharma will be unstoppable if it integrates Ranbaxy well: Amit Rajan, Director, Celogen Life ...

In this interview with ET Now, Amit Rajan, Director, Celogen Life Science talks about Indian pharma companies and US FDA process. Edited excerpts:
Read more: Sun Pharma will be unstoppable if it integrates Ranbaxy well: Amit Rajan, Director, Celogen Life ...

Pharma Reviews: Sun Pharma introduces anti-cancer product in Europe

InfuSMART is a technology in which oncology products are developed in a ready-to-administer (RTA) bag, said the company in a BSE filing.
Read more: Sun Pharma introduces anti-cancer product in Europe

Pharma Reviews: Why can't doctors prescribe generic drugs?

According to a recent study by the leading industrial body ASSOCHAM and market research firm RNCOS, the generic drug market in India is expected ...
Read more: Why can't doctors prescribe generic drugs?

Pharma Reviews: Six Indian firms ink pact to supply HIV, Hepatitis C drugs to WHO

Six Indian pharmaceutical firms, including Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila, are among seven drug makers that ...
Read more: Six Indian firms ink pact to supply HIV, Hepatitis C drugs to WHO

US FDA News: FDA approves Differin Gel 0.1% for over-the-counter use to treat acne

The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.
Read more: FDA approves Differin Gel 0.1% for over-the-counter use to treat acne

Pharma Reviews: Six Indian pharma companies get new licences to supply generic drugs

The UN-backed Medicines Patent Pool (MPP) announced on 7 July new generic manufacturing licensing, for antiretrovirals (ARVs) and direct acting ...
Read more: Six Indian pharma companies get new licences to supply generic drugs

Pharma Reviews: Pharmaceutical Newsletter - July 04 to 08, 2016

The week ended July 8 saw some big events taking place in the global pharmaceutical space. Six Indian companies signed license with UN to provide ...
Read more: Pharmaceutical Newsletter - July 04 to 08, 2016

Pharma Reviews: AKCDA wants Centre to review policy of allowing higher FDI in pharma sector

“The FDI will help the multinationals to take over the retail pharma trade in the Indian market. They will start their manufacturing units first, followed by ...
Read more: AKCDA wants Centre to review policy of allowing higher FDI in pharma sector

Pharma Reviews: Here's why raising FDI cap in defence, pharma is good for Make in India

However, FDI in brownfield investment has been a contentious issue, as concerns have been raised over some M&A of Indian pharma companies by ...
Read more: Here's why raising FDI cap in defence, pharma is good for Make in India

US FDA News: FDA approves first HPV test for use with SurePath Preservative Fluid

The U.S. Food and Drug Administration today approved the Roche cobas HPV Test as the first test for Human Papilloma Virus (HPV) that can be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid.
Read more: FDA approves first HPV test for use with SurePath Preservative Fluid

Pharma Reviews: 6 Indian pharma cos ink licensing pact with UN-backed MPP

Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among seven drug makers which have signed ...
Read more: 6 Indian pharma cos ink licensing pact with UN-backed MPP

Pharma Reviews: Sri Lanka Trade Minister to visit India to encourage Indian pharma cos to set up units in Sri Lanka

The Trade Minister of Sri Lanka will soon visit India to encourage Indian pharmaceutical companies to establish pharma units in Special Economic ...
Read more: Sri Lanka Trade Minister to visit India to encourage Indian pharma cos to set up units in Sri Lanka

Pharma Reviews: GreenSignal Bio Pharma files DRHP for IPO

The Company has signed up with Indian Overseas Bank to be the Global ... many of the traditional businesses in the global pharmaceutical market.
Read more: GreenSignal Bio Pharma files DRHP for IPO

Pharma Reviews: Action initiated against pharma firm

HYDERABAD: The government on Wednesday cracked the whip on Haseeb Pharmaceuticals, the company which supplied saline solution bottles ...
Read more: Action initiated against pharma firm

US FDA News: FDA advances Precision Medicine Initiative by issuing draft guidances on next generation sequencing-based tests

FDA advances Precision Medicine Initiative by issuing draft guidances on next generation sequencing-based tests
Read more: FDA advances Precision Medicine Initiative by issuing draft guidances on next generation sequencing-based tests

US FDA News: Federal court orders Alabama seafood company to cease production due to food safety violations

On Tuesday, July 5, 2016, the U.S. District Court for the Southern District of Alabama entered a consent decree of permanent injunction between the United States and BEK Catering LLC. The business, owned by Billy B. Stembridge, Jr. and Kyle D. Huxen, operates as Floppers Foods selling ready-to-eat seafood products and is based in Daphne, Alabama.
Read more: Federal court orders Alabama seafood company to cease production due to food safety violations

Pharma Reviews: Bayer CropScience appoints Pankaj Patel as Chairman

Pankaj Patel is the Chairman and Managing Director of Zydus Cadila, one of India's leading pharmaceutical groups and an innovation-driven, global ...
Read more: Bayer CropScience appoints Pankaj Patel as Chairman

Pharma Reviews: Top Indian companies rank high in transparency survey

These companies include Motherson Sumi, Maruti, HDFC Bank, IndusInd Bank, Kotak Bank, Sun Pharma, Lupin, Cummins India, L&T, Infosys, TCS ...
Read more: Top Indian companies rank high in transparency survey

Pharma Reviews: India trumped China in pharma exports in 2015

India maintained its supremacy over China in pharmaceutical exports last year, the union commerce ministry said on Tuesday. “India moved ahead of ...
Read more: India trumped China in pharma exports in 2015

Pharma Jobs: Junior Executive-Pharmacology

Company: Bayballs HR Services Private Limited
Qualification: M.Pharm, M.Sc
Experience: 0 to 2
Salary: 2.20 to 2.20
location: Pondicherry
Ref: 18980764
Summary: Involves, reading and complete analysis of the source material (Journals/Patents), which includes identification of the pharmacological effect....
Read more: Junior Executive-Pharmacology

Pharma Jobs: Aurvedic

Company: Universal Hunt Private Limited
Experience: 5 to 15
location: Kolkata
Ref: 18980812
Summary: Set Job Alert ....
Read more: Aurvedic

Pharma Jobs: manager

Company: Cartesian IT Solutions LLP
Qualification: B.Pharm, B.Sc, M.Pharm, M.Sc
Experience: 3 to 5
location: Hyderabad / Secunderabad
Ref: 18981311
Summary: As a Manager, you will join a highly motivated, interdisciplinary team performing R&D and manufacturing for biologics. ​Manages formulation team....
Read more: manager

Pharma Jobs: Production Chemist ( Fda Approved )

Company: Universal Hunt Private Limited
Experience: 4 to 15
location: Other India
Ref: 18981537
Summary: Set Job Alert ....
Read more: Production Chemist ( Fda Approved )

Pharma Jobs: Research Associate (e1/e2)

Company: Universal Hunt Private Limited
Qualification: M.Sc
Experience: 2 to 10
location: Pune
Ref: 18977036
Summary: Set Job Alert ....
Read more: Research Associate (e1/e2)

Pharma Jobs: Manufacturing Chemist

Company: Universal Hunt Private Limited
Experience: 0 to 10
location: Noida
Ref: 18977168
Summary: Set Job Alert ....
Read more: Manufacturing Chemist

Pharma Jobs: Process Engineer- Pharma / Biotech / Clinical Research

Company: Universal Hunt Private Limited
Qualification: Other
Experience: 0 to 5
location: Gurgaon
Ref: 18977460
Summary: Set Job Alert ....
Read more: Process Engineer- Pharma / Biotech / Clinical Research

Pharma Reviews: India's Pharma exports grew from US$11.66bn to US$12.54bn in 2015; beats China

India's exports of Pharma products to US jumped from US $3.84bn to US ... India's pharmaceutical exports continued its lead over China in 2015.
Read more: India's Pharma exports grew from US$11.66bn to US$12.54bn in 2015; beats China

US FDA News: Dream Body 450mg, Dream Body Extreme Gold 800mg, Dream Body Advanced 400mg: Recall - Undeclared Drug Ingredient

Sibutramine may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.
Read more: Dream Body 450mg, Dream Body Extreme Gold 800mg, Dream Body Advanced 400mg: Recall - Undeclared Drug Ingredient

US FDA News: FDA approves first absorbable stent for coronary artery disease

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. The Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), which releases the drug everolimus to limit the growth of scar tissue, is gradually absorbed by the body in approximately three years.
Read more: FDA approves first absorbable stent for coronary artery disease

Pharma Reviews: India maintains lead over China in pharma exports in 2015

NEW DELHI: India's pharmaceutical exports continued its lead over China in ... While India exported $1.5 billion and $3.04 billion-worth of pharma ...
Read more: India maintains lead over China in pharma exports in 2015

Pharma Reviews: Bayer CropScience appoints Pankaj Patel as chairman

With an experience spanning over 40 years in the Indian pharmaceutical industry, Patel combines both research and techno-commercial expertise.
Read more: Bayer CropScience appoints Pankaj Patel as chairman

Pharma Reviews: India maintains its supremacy over China in pharmaceuticals

India's pharmaceutical exports continued its lead over China in 2015. While India's Pharma exports grew from US$ 11.66 billion to US$ 12.54 billion in ...
Read more: India maintains its supremacy over China in pharmaceuticals

Pharma Reviews: India trumped China in pharma exports in 2015

India maintained its supremacy over China in pharmaceutical exports last year ... "India also maintained its lead with growth in EU and Africa recording ...
Read more: India trumped China in pharma exports in 2015

Pharma Reviews: 1mg Technologies acquires diagnostic labs aggregator Medd and other top pharma news

Sri Lanka has invited Indian pharmaceutical companies to set up operations in the country by offering them space in its special economic zones, ...
Read more: 1mg Technologies acquires diagnostic labs aggregator Medd and other top pharma news

Pharma Reviews: SynCore organises PatientSafe India conference to tackle drug counterfeiting challenges

To address the current challenges of drug counterfeiting, SynCore Consulting in collaboration with the industry associations such as OPPI, IDMA, IPA, ...
Read more: SynCore organises PatientSafe India conference to tackle drug counterfeiting challenges

Pharma Reviews: Sri Lanka woos Indian pharma companies to set up operations in the country

Sri Lanka woos Indian pharma companies to set up operations in the ... Indian government officials said this will lead to expansion of the industry ...
Read more: Sri Lanka woos Indian pharma companies to set up operations in the country

Pharma Reviews: Net sales of 100 top pharma cos move up by 10.3% to Rs. 1.9 lakh crore in 2015-16

The leading 100 Indian pharmaceutical companies registered satisfactory financial performance during fiscal year 2015-16 despite quality problems, ...
Read more: Net sales of 100 top pharma cos move up by 10.3% to Rs. 1.9 lakh crore in 2015-16

Pharma Reviews: India's pharma industry expected to grow to $55 bn by 2020

(Photo Courtesy: Getty Images) New York: India's rapidly growing pharmaceutical market is expected to grow to $55 billion by 2020 and emerge as the ...
Read more: India's pharma industry expected to grow to $55 bn by 2020

Pharma Reviews: How foreign stocks are cheaper than Indian peers

From food companies to drug makers, many foreign stocks trade at big discounts to their Indian peers. The Kellogg Company stock quotes at a PE of ...
Read more: How foreign stocks are cheaper than Indian peers

Pharma Reviews: Pharma market in India expected to be worth USD 55 bn by 2020

New York, Jul 2 (PTI) The rapidly growing pharmaceutical market in India is expected to be worth USD 55 billion by 2020, becoming the sixth largest ...
Read more: Pharma market in India expected to be worth USD 55 bn by 2020

Pharma Reviews: India Pharma market expected to be worth USD 55 bn

The pharmaceutical market in India is expected to be worth 55 billion US dollars by 2020, becoming the sixth largest market globally in absolute size, ...
Read more: India Pharma market expected to be worth USD 55 bn

Pharma Reviews: Pharma market in India expected to be worth USD 55 bn by 2020

The rapidly growing pharmaceutical market in India is expected to be worth USD 55 billion by 2020, becoming the sixth largest market globally in ...
Read more: Pharma market in India expected to be worth USD 55 bn by 2020

Pharma Reviews: India's pharma industry expected to grow to $55 bn by 2020

NEW YORK: India's rapidly growing pharmaceutical market is expected to grow to $55 billion by 2020 and emerge as the sixth largest globally by size, ...
Read more: India's pharma industry expected to grow to $55 bn by 2020

Pharma Reviews: India's pharma industry expected to grow to $55 bn by 2020

India's rapidly growing pharmaceutical market is expected to grow to $55 billion by 2020 and emerge as the sixth largest globally by size, said Indian ...
Read more: India's pharma industry expected to grow to $55 bn by 2020

Pharma Reviews: India's share in global pharma pie to go up in 20 yrs: Baring PE

Baring Private Equity is bullish on Indian markets and says that India's ... Indian pharma companies contribute 6 percent to global pharma sales and ...
Read more: India's share in global pharma pie to go up in 20 yrs: Baring PE